142 related articles for article (PubMed ID: 36634619)
1. Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes.
Holt RA
Cell Host Microbe; 2023 Jan; 31(1):141-145. PubMed ID: 36634619
[TBL] [Abstract][Full Text] [Related]
2. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
5. Genetic Transformation of Fusobacterium nucleatum.
Yoshida A; Ikegami A
Methods Mol Biol; 2021; 2210():43-50. PubMed ID: 32815126
[TBL] [Abstract][Full Text] [Related]
6. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
[TBL] [Abstract][Full Text] [Related]
7. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
8. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
[TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell-Like Features by Manipulating Lipid Droplet-Mediated Numb Degradation.
Liu H; Du J; Chao S; Li S; Cai H; Zhang H; Chen G; Liu P; Bu P
Adv Sci (Weinh); 2022 Apr; 9(12):e2105222. PubMed ID: 35170250
[TBL] [Abstract][Full Text] [Related]
10.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
11. The who, where and how of fusobacteria and colon cancer.
Sears CL
Elife; 2018 Mar; 7():. PubMed ID: 29533185
[TBL] [Abstract][Full Text] [Related]
12. Tubeimuside I improves the efficacy of a therapeutic
Tong Y; Lu G; Wang Z; Hao S; Zhang G; Sun H
Front Immunol; 2023; 14():1154818. PubMed ID: 37207216
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
Castellarin M; Warren RL; Freeman JD; Dreolini L; Krzywinski M; Strauss J; Barnes R; Watson P; Allen-Vercoe E; Moore RA; Holt RA
Genome Res; 2012 Feb; 22(2):299-306. PubMed ID: 22009989
[TBL] [Abstract][Full Text] [Related]
14. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
[TBL] [Abstract][Full Text] [Related]
15. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
[TBL] [Abstract][Full Text] [Related]
16. New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
Slade DJ
Trends Cancer; 2021 Mar; 7(3):185-187. PubMed ID: 33309240
[TBL] [Abstract][Full Text] [Related]
17. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
18. Fusobacterium nucleatum - Friend or foe?
Stokowa-Sołtys K; Wojtkowiak K; Jagiełło K
J Inorg Biochem; 2021 Nov; 224():111586. PubMed ID: 34425476
[TBL] [Abstract][Full Text] [Related]
19. Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins.
Zanzoni A; Spinelli L; Braham S; Brun C
Microbiome; 2017 Aug; 5(1):89. PubMed ID: 28793925
[TBL] [Abstract][Full Text] [Related]
20. A crucial Fusobacterium nucleatum clade in colorectal cancer.
Ray K
Nat Rev Gastroenterol Hepatol; 2024 Jun; 21(6):375. PubMed ID: 38627536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
